IRIDEX Corp IRIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.09
- Day Range
- $1.09–1.15
- 52-Week Range
- $0.87–1.65
- Bid/Ask
- $1.11 / $1.20
- Shares Outstanding
- 17.41M
- Market Cap
- $19.32M
- Volume/Avg
- 285 / 253,438
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.36
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 108
- Website
- https://www.iridex.com
Competitors
Valuation
|
Metric
|
IRIX
|
AFX
|
|---|---|---|
Price/Earnings (Normalized) | — | 15.65 |
Price/Book Value | — | 1.11 |
Price/Sales | 0.36 | 1.05 |
Price/Cash Flow | — | 9.49 |
Price/Earnings
IRIX
AFX
Financial Strength
|
Metric
|
IRIX
|
AFX
|
|---|---|---|
Quick Ratio | 1.01 | 1.40 |
Current Ratio | 1.92 | 2.34 |
Interest Coverage | — | 8.04 |
Quick Ratio
IRIX
AFX
Profitability
|
Metric
|
IRIX
|
AFX
|
|---|---|---|
Return on Assets (Normalized) | −8.79% | — |
Return on Equity (Normalized) | — | — |
Return on Invested Capital (Normalized) | −29.47% | — |
Return on Assets
IRIX
AFX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Vmtylhjh | Srqjq | $158B | |||
| Stryker Corp
SYK
| Pjltjxpygf | Shvts | $116B | |||
| Medtronic PLC
MDT
| Qmbfnmd | Fjrcly | $104B | |||
| Boston Scientific Corp
BSX
| Prfbmgqbp | Qwnmzvs | $72B | |||
| Edwards Lifesciences Corp
EW
| Glddgpldt | Czsjm | $49B | |||
| DexCom Inc
DXCM
| Qrgfpxgkwx | Ttwxmc | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Fngczbvb | Pmfy | $29B | |||
| Koninklijke Philips NV ADR
PHG
| Mgzht | Dqmpv | $26B | |||
| Steris PLC
STE
| Ftryzczd | Dcdggfl | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Mmsydhlzy | Srnc | $17B |
United States